Gurnari C, Nautiyal I, & Pagliuca S. (2021). Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria. Dove Medical Press.
Chicago Style (17th ed.) CitationGurnari C, Nautiyal I, and Pagliuca S. Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria. Dove Medical Press, 2021.
MLA (9th ed.) CitationGurnari C, et al. Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria. Dove Medical Press, 2021.
Warning: These citations may not always be 100% accurate.